Fundraising Fox
/People
Sign in

Krishnan Nandabalan

InvestorFounder

CEO, Founder, & President, InveniAI at AIF · Chief Executive Officer, President and Chairman at Invea Therapeutics, Inc.

Branford, Connecticut, United States

FoundedInvea Therapeutics, Inc.

Find your path to Krishnan

Sign up to see every warm intro you have to Krishnan

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Krishnan. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Krishnan Nandabalan is President, Chairman, and CEO of AlphaMeld Corporation and President and CEO of InveniAI Corporation, a technology spinout focused on applying big data analytics and machine learning to drug and target discovery. With over two decades in pharmaceutical and biotechnology R&D, operations, and business development, he has completed licensing and M&A transactions with major industry players and previously served as VP of Corporate Development at Genaissance Pharmaceuticals and Group Leader of Functional Genomics at CuraGen Corporation. He holds a Ph.D. in Biochemistry and Molecular Biology from the Indian Institute of Science, completed a postdoctoral fellowship at Yale University, and has 12 issued patents and publications in peer-reviewed journals including Cell and Science.

Chief Executive Officer, President and Chairman at Invea Therapeutics, Inc.

Intro paths

→

In turn, Krishnan can intro founders to Invea Therapeutics, Inc.'s investors below.

Invea Therapeutics, Inc.'s investors · 1

Connecticut InnovationsNew Haven · $500K – $2M checks

Colleagues at AIF

Alison Singer
Co-Founder & President, Autism Science Foundation at AIF
Amanda Lukof
Special Needs Advocate at AIF
Arun Gupta
Founder & CEO, Quartet, Accretive, The World Bank, McKinsey at AIF
Ashok Srinivasan
Chief Science Advisor at AIF
Bob Nelsen
Co-Founder & Managing Director, ARCH Venture Partners at AIF
Brian Jacobs
Venture Capitalist Emergence, Moai Capital at AIF
Brian O'Callaghan
Co-Founder at AIF
Christopher Male
Co-Founder & Managing Partner at AIF

Frequently asked questions

Who is Krishnan Nandabalan?
Krishnan Nandabalan is President, Chairman, and CEO of AlphaMeld Corporation and President and CEO of InveniAI Corporation, a technology spinout focused on applying big data analytics and machine learning to drug and target discovery. With over two decades in pharmaceutical and biotechnology R&D, operations, and business development, he has completed licensing and M&A transactions with major industry players and previously served as VP of Corporate Development at Genaissance Pharmaceuticals and Group Leader of Functional Genomics at CuraGen Corporation. He holds a Ph.D. in Biochemistry and Molecular Biology from the Indian Institute of Science, completed a postdoctoral fellowship at Yale University, and has 12 issued patents and publications in peer-reviewed journals including Cell and Science.
Where does Krishnan Nandabalan work?
Krishnan Nandabalan is Chief Executive Officer, President and Chairman of Invea Therapeutics, Inc. and CEO, Founder, & President, InveniAI at AIF.
What companies did Krishnan Nandabalan found?
Krishnan Nandabalan founded Invea Therapeutics, Inc..

Founder mafias

About this profile. Compiled from public sources — AIF's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights